Valor202020212022202320242025TTMGastos comerciales, generales y administrativos22.08 B24.66 B24.77 B21.51 B22.87 B23.68 B23.68 BInvestigación y desarrollo12.16 B14.71 B14.6 B483 M1.84 B109 M14.66 BBeneficio operativo14.67 B18.65 B18.37 B30.43 B31.49 B35.12 B16.82 BTotal de ingresos no operativos-3 B-672 M-1.71 B-5.74 B-3.58 B8.01 B8.27 BGastos por intereses, netos de intereses capitalizados201 M183 M276 M772 M755 M971 M971 MIngresos no operativos, una vez deducidos los gastos por intereses-299 M-366 M-114 M123 M363 M-169 M85 MIngresos/gastos extraordinarios-2.9 B-489 M-1.87 B-6.63 B-4.69 B7.21 B7.21 BBeneficio antes de impuestos16.5 B22.78 B21.73 B15.06 B16.69 B32.58 B32.58 BParticipación en los beneficios———————Impuestos1.78 B1.9 B3.78 B1.74 B2.62 B5.78 B5.78 BParticipación minoritaria———————Otros ingresos/gastos después de impuestos———————Beneficio neto antes de actividades interrumpidas14.71 B20.88 B17.94 B13.33 B14.07 B26.8 B26.8 BOperaciones suspendidas———21.83 B00—Beneficio neto14.71 B20.88 B17.94 B35.15 B14.07 B26.8 B26.8 BAjuste por dilución———————Dividendos de las acciones preferentes———————Beneficio neto diluido atribuible a los accionistas14.71 B20.88 B17.94 B35.15 B14.07 B26.8 B26.8 BBeneficio básico por acción5.597.936.8313.885.8411.1311.13Beneficio por acción diluido5.517.816.7313.725.7911.0311.03Número medio de acciones ordinarias2.63 B2.63 B2.63 B2.53 B2.41 B2.41 B9.63 BAcciones diluidas2.67 B2.67 B2.66 B2.56 B2.43 B2.43 B9.7 BEBITDA21.9 B26.04 B25.34 B37.91 B38.83 B42.62 B24.32 BEBIT14.67 B18.65 B18.37 B30.43 B31.49 B35.12 B16.82 BCosto de los ingresos28.43 B29.86 B31.09 B26.55 B27.47 B30.26 B30.26 BOtros costes de producción———————Amortización y depreciación (flujo de caja)7.23 B7.39 B6.97 B7.49 B7.34 B7.5 B7.5 B
Johnson & Johnson
Johnson & Johnson is an American multinational pharmaceutical, biotechnology, and medical technologies corporation headquartered in New Brunswick, New Jersey, and publicly traded on the New York Stock Exchange. Its common stock is a component of the Dow Jones Industrial Average, and the company is ranked No. 48 on the 2025 Fortune 500 list of the largest United States corporations. In 2025, the company was ranked 42nd in the Forbes Global 2000. Johnson & Johnson has a global workforce of approximately 138,000 employees who are led by the company's current chairman and chief executive officer, Joaquin Duato. Johnson & Johnson is one of the world's most valuable companies and is one of only two U.S.-based companies that has a prime credit rating of AAA.
Johnson & Johnson was founded in 1886 by three brothers, Robert Wood Johnson, James Wood Johnson, and Edward Mead Johnson, selling ready-to-use sterile surgical dressings.